MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number MDT-TRANS VALVE |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Stroke/CVA (1770); Non specific EKG/ECG Changes (1817); Hemorrhage/Bleeding (1888); Myocardial Infarction (1969); Rupture (2208); Cardiovascular Insufficiency (4445); Heart Failure/Congestive Heart Failure (4446)
|
Event Date 01/01/2024 |
Event Type
Injury
|
Event Description
|
Literature was reviewed regarding one-year clinical outcomes of self-expanding or balloon-expandable transcatheter aortic valves. the study population included 1,174 patients with a mean age of 82 years who were predominantly female. multiple manufacturer¿s devices were implanted in the study population; 1,098 patients were implanted with a medtronic evolut pro or evolut pro+ bioprosthetic valve. deaths occurred in the study population; however, there was no statement establishing a causal or contributory relationship between medtronic product and the deaths. among all patients adverse events included stroke and congestive heart failure requiring hospitalization. no further information was provided pertaining to medtronic products.
|
|
Manufacturer Narrative
|
Citation: costa et al. one-year clinical outcomes of transcatheter aortic valve implantation with the latest iteration of self-expanding or balloon expandable devices: insights from the opera-tavi registry.Euro intervention.2024 jan 1;20(1):95-103.Doi: 10.4244/eij-d-23-00720.Earliest date of publication used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Additional adverse events from supplementary data tables.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Among all patients, additional adverse events included: annular rupture, coronary obstruction, major bleeding or vascular complication, arrhythmia requiring permanent pacemaker implant, myocardial infarction, and acute kidney injury.No further information was provided pertaining to medtronic products.
|
|
Search Alerts/Recalls
|
|
|